Guard Therapeutics International AB (publ)
SSE:GUARD.ST
Overview | Financials
Company Name | Guard Therapeutics International AB (publ) |
Symbol | GUARD.ST |
Currency | SEK |
Price | 19.8 |
Market Cap | 199,219,680 |
Dividend Yield | 0% |
52-week-range | 5.1 - 62.5 |
Industry | Biotechnology |
Sector | Healthcare |
CEO | Mr. Tobias Larsson Agervald |
Website | https://guardtherapeutics.com |
An error occurred while fetching data.
About Guard Therapeutics International AB (publ)
Guard Therapeutics International AB (publ), a pharmaceutical company, identifies, develops, and commercializes therapies for the diagnosis and treatment of acute kidney injuries in Sweden. It offers ROSGard, a biological drug candidate that prevents kidney damage by protecting, cleaning, and repairing the exposed cells and tissues. The company was formerly known
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD